Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

Understanding the Prevalence of ABSSSI in the Community
Panelists discuss the prevalence of acute bacterial skin and skin structure infections, including MRSA, in the community, as well as risk factors, susceptibility, and increased resistance to oral antibiotics such as Keflex.
An Overview of ABSSSI
Peter L. Salgo, MD; Yoav Golan, MD; and Bruce M. Jones, PharmD, BCPS, identify the commonalities of ABSSSI, including the predominant pathogens, such as Staphylococcus aureus and Streptococcus, and gram-positive infections.
Pseudomonas Infections: Selecting Upfront Antibiotics
Panelists reflect on their personal upfront approaches to treating Pseudomonas infections before lab results return, considering monotherapy versus treatment cocktails and the inherent risks that need to be accounted for.  
Initial Therapy for MDR Bacteria and Antibiotic Resistance
Jason Gallagher, PharmD, discusses the importance of appropriate initial therapy and the mechanism of resistance of multidrug-resistant bacteria.
A Vaccine for <em>Clostridium difficile</em>: Current Progress
Xingmin Sun, PhD, shares current progress on developing a vaccine for Clostridium difficile infection.
A Vaccine for <em>Clostridium difficile</em>: What to Consider
Xingmin Sun, PhD, discusses aspects that need to be considered before developing a vaccine for Clostridium difficile.
Why Might Hospital Length-of-Stay Be Shorter in Patients on a Fluoroquinolone?
Chelsea Drennan, PharmD(c) explains why hospital length-of-stay might be shorter in patients who are on a fluoroquinolone versus a beta-lactam.
<i>Pseudomonas</i> Infections: Optimizing Diagnostic Strategies
Panelists provide considerations for the optimal approaches to diagnosing Pseudomonas infections and identify where imaging and rapid diagnostics fit into the paradigm.
Big advances in treatment can